Location History:
- Edogawa-ku, JP (2012)
- Tokyo, JP (2004 - 2015)
Company Filing History:
3 out of 200 
3 out of 441 
1 out of 52 Years Active: 2004-2015
Title: The Innovations of Nobuo Machinaga
Introduction
Nobuo Machinaga is a distinguished inventor based in Tokyo, Japan. With a remarkable portfolio of seven patents, he has made significant contributions to the field of pharmaceuticals. His innovative work primarily focuses on compounds that affect lymphocyte levels, showcasing his expertise in medicinal chemistry.
Latest Patents
Among Nobuo Machinaga's latest inventions are two noteworthy patents. The first patent revolves around phosphoric acid ester derivatives, aimed at providing a novel compound with S1P lyase inhibitory ability. This compound is noted for its capability to induce a reduction in the number of lymphocytes, and it also includes a pharmaceutically acceptable salt and a pharmaceutical composition containing this compound as an active ingredient. The general formula (I) represents this innovative compound.
The second patent details an imidazole derivative that offers a similar function. It focuses on creating a novel compound, an isotope thereof, or a pharmaceutically acceptable salt that possesses S1P lyase inhibitory capacity, thereby inducing a decrease in lymphocyte numbers. This invention also includes pharmaceutical compositions comprised of these active ingredients, represented by general formula (I) or (II) and its isotopes.
Career Highlights
Throughout his career, Nobuo Machinaga has worked with prominent pharmaceutical companies. Notably, he has been associated with Daiichi Pharmaceutical Co., Ltd. and Daiichi Sankyo Company, Limited. His experience in these organizations has significantly influenced his research and the patents he has registered.
Collaborations
Nobuo's work in the field has not been a solo effort. He has collaborated with talented individuals such as Jun Chiba and Atsushi Nakayama, contributing to the development of innovative compounds and enhancing their effectiveness in addressing health concerns.
Conclusion
In conclusion, Nobuo Machinaga is a prolific inventor whose patents reflect a deep commitment to advancing pharmaceutical science. His latest innovations around lymphocyte regulation through novel compounds not only hold promise for future therapies but also underline his status as a key player in the field of medicinal chemistry.